Pelvic lipomatosis is a rare benign disease, associated with overgrowth of fat in the perivesical and perirectal area. It is of unknown etiology. We describe a 45-year-old male with pelvic lipomatosis causing bladder storage dysfunction symptoms and pelvic pain that affected his quality of life. Surgical excision of the pelvic mass with bladder preservation was performed. After surgery, the patient had a marked improvement in his quality of life, with resolution of bladder storage dysfunction symptoms and pelvic pain.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165674 | PMC |
| http://dx.doi.org/10.5173/ceju.2014.03.art15 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pelvic lipomatosis-a rare diagnosis and a challenging management: a case report and literature review.
J Surg Case Rep
December 2024
Urology Department, Hamad Medical Corporation, Doha, Qatar.
Pelvic lipomatosis (PL) involves nonmalignant excess fat growth in perirectal and perivesical areas, gaining recognition over three decades. This review addresses its clinicopathological aspects amid controversies, emphasizing the need for a comprehensive examination of current literature. This report outlines a 42-year-old man's diagnostic journey for persistent urological symptoms, ultimately identified as PL.
View Article and Find Full Text PDFConstructing different machine learning models for identifying pelvic lipomatosis based on AI-assisted CT image feature recognition.
Abdom Radiol (NY)
October 2024
Shanghai Changhai Hospital, Naval Medical University, Shanghai, China.
[Efficacy of coated metal ureteral stent in the treatment of pelvic lipomatosis induced hydronephrosis].
Beijing Da Xue Xue Bao Yi Xue Ban
October 2024
Department of Urology, Peking University People's Hospital; The Institute of Applied Lithotripsy Technology, Peking University, Beijing 100044, China.
Article Synopsis
- The study investigates the effectiveness of coated metal ureteral stents (CMUS) in treating pelvic lipomatosis-induced hydronephrosis (PLH) in 8 male patients from 2018 to 2021.
- Key inclusion criteria included excessive fat around the bladder and evidence of hydronephrosis, while patients with ureteral atresia or recurrent bladder obstruction were excluded.
- Outcomes showed a significant improvement post-operation, with decreased serum creatinine levels and reduced renal pelvis width, indicating successful management of hydronephrosis.
[Etiological analysis of hydronephrosis in adults: A single-center cross-sectional study].
Beijing Da Xue Xue Bao Yi Xue Ban
October 2024
Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China.
Article Synopsis
- * A total of 767 adult patients were examined, excluding those with ureteral stones or tumors, with data collected over a year at Peking University First Hospital.
- * Findings revealed that non-surgical factors like urinary malformations were the leading cause in over 60% of cases, while iatrogenic injuries from surgeries accounted for about 27% of the cases studied.
Successful treatment of SAPHO syndrome co-occurred with pelvic lipomatosis with adalimumab: A case report.
Int J Rheum Dis
October 2024
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!